Literature DB >> 12549914

SRp55 is a regulator of calcitonin/CGRP alternative RNA splicing.

Quincy Tran1, James R Roesser.   

Abstract

Alternative splicing is an important mechanism for the regulation of gene expression. The mammalian calcitonin/calcitonin gene-related peptide (CGRP) pre-mRNA is alternatively spliced in a tissue-specific manner, leading to the production of calcitonin mRNA containing exons 1-4 in thyroid C cells and CGRP mRNA containing exons 1-3, 5, and 6 in neurons. The calcitonin-specific fourth exon contains an exonic splice enhancer (ESE) that binds SRp55. We define the RNA binding site of SRp55 in the ESE and demonstrate that base changes that decrease the level of SRp55 binding decrease the level of calcitonin splicing in vitro and calcitonin mRNA production in vivo. Base changes that increase the affinity of SRp55 for the ESE increase the level of calcitonin splicing in vitro and calcitonin mRNA levels in 293 cells. We also observe that SRp55 levels in different cell types correlate with the levels of calcitonin mRNA produced in these cells. Finally, we show that increasing the level of cellular expression of SRp55 stimulates calcitonin mRNA production in vivo. These observations suggest that SRp55 binding to a suboptimal RNA binding site in the calcitonin/CGRP pre-mRNA ESE is required for calcitonin mRNA production. Differential amounts of SRp55 present in different cell types would then control calcitonin/CGRP alternative splicing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12549914     DOI: 10.1021/bi026753a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

Review 1.  Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression.

Authors:  Zhi-Ming Zheng
Journal:  J Biomed Sci       Date:  2004 May-Jun       Impact factor: 8.410

Review 2.  The RNAissance family: SR proteins as multifaceted regulators of gene expression.

Authors:  Jonathan M Howard; Jeremy R Sanford
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-08-22       Impact factor: 9.957

3.  Chironomus tentans-repressor splicing factor represses SR protein function locally on pre-mRNA exons and is displaced at correct splice sites.

Authors:  Petra Björk; Ingela Wetterberg-Strandh; Göran Baurén; Lars Wieslander
Journal:  Mol Biol Cell       Date:  2005-10-19       Impact factor: 4.138

4.  A nuclear function of Hu proteins as neuron-specific alternative RNA processing regulators.

Authors:  Hui Zhu; Robert A Hasman; Victoria A Barron; Guangbin Luo; Hua Lou
Journal:  Mol Biol Cell       Date:  2006-10-11       Impact factor: 4.138

5.  Role for Fox-1/Fox-2 in mediating the neuronal pathway of calcitonin/calcitonin gene-related peptide alternative RNA processing.

Authors:  Hua-Lin Zhou; Andrew P Baraniak; Hua Lou
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

6.  Repression of prespliceosome complex formation at two distinct steps by Fox-1/Fox-2 proteins.

Authors:  Hua-Lin Zhou; Hua Lou
Journal:  Mol Cell Biol       Date:  2008-06-23       Impact factor: 4.272

7.  Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.

Authors:  Yong Zhu; Derek Leaderer; Carly Guss; Heather N Brown; Yawei Zhang; Peter Boyle; Richard G Stevens; Aaron Hoffman; Qin Qin; Xuesong Han; Tongzhang Zheng
Journal:  Int J Cancer       Date:  2007-01-15       Impact factor: 7.396

8.  ADAR1-Mediated RNA Editing, A Novel Mechanism Controlling Phenotypic Modulation of Vascular Smooth Muscle Cells.

Authors:  Jia Fei; Xiao-Bing Cui; Jia-Ning Wang; Kun Dong; Shi-You Chen
Journal:  Circ Res       Date:  2016-05-19       Impact factor: 17.367

9.  Both U2 snRNA and U12 snRNA are required for accurate splicing of exon 5 of the rat calcitonin/CGRP gene.

Authors:  James R Roesser
Journal:  RNA       Date:  2004-08       Impact factor: 4.942

Review 10.  Fox-1 family of RNA-binding proteins.

Authors:  Hidehito Kuroyanagi
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.